Pieris Pharmaceuticals, Inc.: Revision history

20 August 2022

• curprev 13:2713:27, 20 August 2022 95.149.241.133 talk 1,672 bytes +11 No edit summary undo

13 August 2022

• curprev 20:1420:14, 13 August 2022 109.180.50.163 talk 1,661 bytes +15 No edit summary undo

30 July 2022

• curprev 19:5919:59, 30 July 2022 172.18.0.2 talk 1,646 bytes +1,646 Created page with "Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clini..."